Neomycin

70 Cited Publications
Avis client

Based on 70 publication(s) in Google Scholar

Neomycin, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin is a known phospholipase C (PLC) inhibitor. Neomycin potently inhibits both the nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis. Neomycin inhibits IP3-mediated Ca2+ release, MgATP-dependent Ca2+ uptake, and electrical excitation-evoked skeletal muscle Ca2+ transients. Neomycin depletes gut microbiota in specific mouse models, causes hearing impairment, and kidney damage with prolonged exposure. Neomycin can be used for the research of cancer.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Neomycin

More
Customer Validation & Images
In Vivo Efficacy StudyPK/PD AnalysisOthersBio/Physico-chemical Assay
  • In Vivo Efficacy Study
  • Others
  • PK/PD Analysis
  • Bio/Physico-chemical Assay

Voir tous les produits spécifiques à Isoform Antibiotic

More

Voir tous les produits spécifiques à Isoform Phospholipase

More
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00